Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals


July 27, 2010 7:41 am | News | Comments

Daiichi Sankyo, Inc. announced that the U.S. Food and Drug Administration approved TRIBENZOR, a new three-in-one combination product taken once-daily for the treatment of hypertension.


Cempra Completes Trial of Potent Antibiotic

July 27, 2010 7:32 am | News | Comments

Cempra Pharmaceuticals announced the successful completion of Phase 1 clinical trials of its oral formulation of CEM-101, which showed good tolerability in those studies.


Study Investigates Importance of Fresh Blood

July 27, 2010 7:16 am | by Lauren Neergaard | News | Comments

Facing surgery? You could receive blood that's been stored for a week, or three weeks, or nearly six - and there's growing concern that people who get the older blood might not fare as well.


Graphene Sheet Electrically Sequences DNA

July 27, 2010 7:11 am | News | Comments

Researchers at the University of Pennsylvania have developed a new, carbon-based nanoscale platform to electrically detect single DNA molecules.


Monash Researchers Turn Fat Into Stem Cells

July 27, 2010 7:05 am | News | Comments

Australian scientists from the Monash Institute of Medical Research have reprogrammed adult mouse fat cells and neural cells to become stem cells that can differentiate into a variety of different cells, pluripotency.


VARI Partners to Develop Phase 1 Cancer Program

July 27, 2010 6:57 am | News | Comments

Cancer patients in West Michigan will soon have the opportunity to access new drugs being developed to fight their disease due to a partnership being formed in Grand Rapids.


Onyx Says Carfilzomib Results Promising

July 27, 2010 6:52 am | News | Comments

Onyx Pharmaceuticals Inc. reported positive clinical trial results for its cancer drug candidate, saying it worked for some multiple myeloma patients who have seen other therapies fail.


Compound Decreases Metabolic Problems From Obesity

July 27, 2010 6:45 am | News | Comments

An experimental compound appears to improve metabolic abnormalities associated with obesity, according to a preliminary study led by researchers at the National Institutes of Health. A report of the study, which was conducted with obese mice, appears online in the Journal of Clinical Investigation.


Merck Partnering With Sinopharm On Vax

July 27, 2010 6:33 am | News | Comments

Merck & Co. said it will team up with Sinopharm, a huge Chinese distributor and maker of pharmaceutical and other health products, to market vaccines and potentially other drugs.


Portable Temperature Control

July 26, 2010 8:05 am | Product Releases | Comments

The TG40 System from Centeo Biosciences Ltd. enables rapid screening of experimental temperature conditions from 4ºC to 60ºC and portable temperature control maintains set temperature during analysis.


Sequencing Kit

July 26, 2010 8:00 am | Product Releases | Comments

Illumina, Inc. has launched the TruSeq SBS Sequencing kit, which will enable high-quality paired end reads of 150 base pairs, increase the output of high-quality base calls, and enhance throughput to greater than 95 Gigabases per run on Illumina's Genome Analyzer sequencing system.


Thermo Establishing Tokyo Biomarker Research Center

July 26, 2010 7:50 am | News | Comments

The collaboration between Thermo Fisher's Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center and the Tokyo Medical University Hospital means to establish and support a new Biomarker Research Center in Tokyo, Japan to focus on biomarker discovery and quantification.


FTC Accuses Watson of Obstructing Investigation

July 26, 2010 7:44 am | News | Comments

The Federal Trade Commission has accused Watson Pharmaceuticals Inc. of delaying an investigation into a potential "pay-for-delay" deal on a generic sleep disorder drug.


Many Genetic Variations Responsible for HTG

July 26, 2010 7:36 am | News | Comments

It can make blood look like cream of tomato soup. Patients with high levels of triglycerides in their blood, a disease called hypertriglyceridemia face an increased risk for heart disease and stroke.


Key Enzyme Reverses Sun Damage

July 26, 2010 7:26 am | News | Comments

For the first time, researchers have witnessed how the enzyme photolyase works at the atomic level to repair sun-damaged DNA.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.